Natural killer cell activity of prostatic cancer patients

B. K. Choe, P. Frost, M. K. Morrison, N. R. Rose

Research output: Contribution to journalArticle

Abstract

Natural killer (NK) cell activity of prostatic cancer patients was compared with that of control groups by the radioactive indium (IIIIn) release assay using the K562 and H494 cells as targets. Patients suffering from advanced prostatic cancer (clinical stages C and D) exhibited significantly lower NK activity against K562 cells (28 ± 18% than did the normal group (41 ± 19% The lower NK activity of these patients is not related to their age, since patients in the same age range with localized cancer (stage B) or benign prostatic hyperplasia did not show low NK activity (37% ± 19% This lower NK activity is not due to a depletion of the NK cell precursor population, since the NK activity of advanced cancer patients improves significantly after in vitro incubation with interferon. The NK activity of normal subjects or patient groups showed wide fluctuations during the 18-month observation period. Because of these interassay variations, it is necessary to use standard control subjects during long-term monitoring of the NK activity of the patients.

Original languageEnglish (US)
Pages (from-to)285-291
Number of pages7
JournalCancer Investigation
Volume5
Issue number4
DOIs
StatePublished - 1987

Fingerprint

Natural Killer Cells
Prostatic Neoplasms
K562 Cells
Indium
Prostatic Hyperplasia
Interferons
Neoplasms
Observation
Control Groups
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Choe, B. K., Frost, P., Morrison, M. K., & Rose, N. R. (1987). Natural killer cell activity of prostatic cancer patients. Cancer Investigation, 5(4), 285-291. https://doi.org/10.1080/07357908709170101

Natural killer cell activity of prostatic cancer patients. / Choe, B. K.; Frost, P.; Morrison, M. K.; Rose, N. R.

In: Cancer Investigation, Vol. 5, No. 4, 1987, p. 285-291.

Research output: Contribution to journalArticle

Choe, BK, Frost, P, Morrison, MK & Rose, NR 1987, 'Natural killer cell activity of prostatic cancer patients', Cancer Investigation, vol. 5, no. 4, pp. 285-291. https://doi.org/10.1080/07357908709170101
Choe, B. K. ; Frost, P. ; Morrison, M. K. ; Rose, N. R. / Natural killer cell activity of prostatic cancer patients. In: Cancer Investigation. 1987 ; Vol. 5, No. 4. pp. 285-291.
@article{042bdb52d7994e68b3d1817902f01c22,
title = "Natural killer cell activity of prostatic cancer patients",
abstract = "Natural killer (NK) cell activity of prostatic cancer patients was compared with that of control groups by the radioactive indium (IIIIn) release assay using the K562 and H494 cells as targets. Patients suffering from advanced prostatic cancer (clinical stages C and D) exhibited significantly lower NK activity against K562 cells (28 ± 18{\%} than did the normal group (41 ± 19{\%} The lower NK activity of these patients is not related to their age, since patients in the same age range with localized cancer (stage B) or benign prostatic hyperplasia did not show low NK activity (37{\%} ± 19{\%} This lower NK activity is not due to a depletion of the NK cell precursor population, since the NK activity of advanced cancer patients improves significantly after in vitro incubation with interferon. The NK activity of normal subjects or patient groups showed wide fluctuations during the 18-month observation period. Because of these interassay variations, it is necessary to use standard control subjects during long-term monitoring of the NK activity of the patients.",
author = "Choe, {B. K.} and P. Frost and Morrison, {M. K.} and Rose, {N. R.}",
year = "1987",
doi = "10.1080/07357908709170101",
language = "English (US)",
volume = "5",
pages = "285--291",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Natural killer cell activity of prostatic cancer patients

AU - Choe, B. K.

AU - Frost, P.

AU - Morrison, M. K.

AU - Rose, N. R.

PY - 1987

Y1 - 1987

N2 - Natural killer (NK) cell activity of prostatic cancer patients was compared with that of control groups by the radioactive indium (IIIIn) release assay using the K562 and H494 cells as targets. Patients suffering from advanced prostatic cancer (clinical stages C and D) exhibited significantly lower NK activity against K562 cells (28 ± 18% than did the normal group (41 ± 19% The lower NK activity of these patients is not related to their age, since patients in the same age range with localized cancer (stage B) or benign prostatic hyperplasia did not show low NK activity (37% ± 19% This lower NK activity is not due to a depletion of the NK cell precursor population, since the NK activity of advanced cancer patients improves significantly after in vitro incubation with interferon. The NK activity of normal subjects or patient groups showed wide fluctuations during the 18-month observation period. Because of these interassay variations, it is necessary to use standard control subjects during long-term monitoring of the NK activity of the patients.

AB - Natural killer (NK) cell activity of prostatic cancer patients was compared with that of control groups by the radioactive indium (IIIIn) release assay using the K562 and H494 cells as targets. Patients suffering from advanced prostatic cancer (clinical stages C and D) exhibited significantly lower NK activity against K562 cells (28 ± 18% than did the normal group (41 ± 19% The lower NK activity of these patients is not related to their age, since patients in the same age range with localized cancer (stage B) or benign prostatic hyperplasia did not show low NK activity (37% ± 19% This lower NK activity is not due to a depletion of the NK cell precursor population, since the NK activity of advanced cancer patients improves significantly after in vitro incubation with interferon. The NK activity of normal subjects or patient groups showed wide fluctuations during the 18-month observation period. Because of these interassay variations, it is necessary to use standard control subjects during long-term monitoring of the NK activity of the patients.

UR - http://www.scopus.com/inward/record.url?scp=0023088142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023088142&partnerID=8YFLogxK

U2 - 10.1080/07357908709170101

DO - 10.1080/07357908709170101

M3 - Article

C2 - 2444316

AN - SCOPUS:0023088142

VL - 5

SP - 285

EP - 291

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 4

ER -